Dimensional Fund Advisors’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
BCM
MF
FTCM
Dimensional Fund Advisors's SWTX Position: Q2 2025 in Review
Dimensional Fund Advisors sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 555,888 shares — an estimated $24.5M sold.
Dimensional Fund Advisors first reported a position in SWTX in Q2 2021 and held it in 16 quarters. The position peaked at $44.6M in Q1 2024. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- Dimensional Fund Advisors reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- Dimensional Fund Advisors sold 555,888 SpringWorks Therapeutics shares in Q2 2025, an estimated $24.5M.
- Dimensional Fund Advisors first reported a position in SpringWorks Therapeutics in Q2 2021 and held it in 16 quarters.
- Dimensional Fund Advisors's SpringWorks Therapeutics position peaked at $44.6M in Q1 2024.
- 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.